D-1251-2014 Class I Terminated

Recalled by Shire Human Genetic Therapies, Inc. — Lexington, MA

Recall Details

Product Type
Drugs
Report Date
April 30, 2014
Initiation Date
March 14, 2014
Termination Date
August 31, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8359 vials

Product Description

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.

Reason for Recall

Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.

Distribution Pattern

US Nationwide including Puerto Rico; Mexico, Columbia

Code Information

US: Lot #: FEW13-001, FEW13-002, FED13-006; Expiry: 10/15. Mexico: Lot #: FED 013-010; Expiry: 10/15. Columbia: Lot #: FED 013-011; Expiry: 10/15.